In a recent study published in the journal Science Advances, researchers described a deep learning (DL)-based reconstruction framework to accelerate brain magnetic resonance imaging (MRI) at 0.055 ...
An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors. This is an ASCO Meeting ...
A recent Radiology journal study assesses the power of a fully automated deep learning (DL) model to produce deterministic outputs for identifying clinically significant prostate cancer (csPCa). Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback